Back to top

Press Releases

Zacks Equity Research

The Zacks Analyst Blog Highlights: Cabot Oil & Gas, Zayo Group Holdings, Etsy, Live Nation Entertainment and Vertex Pharmaceuticals

COG ZAYO ETSY LYV VRTX

Trades from $3

For Immediate Release

Chicago, IL – November 07, 2016 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Cabot Oil & Gas Corporation (NYSE:(COG - Free Report) –Free Report),Zayo Group Holdings, Inc. (NYSE:(ZAYO - Free Report) –Free Report),Etsy, Inc. (NASDAQ:(ETSY - Free Report) –Free Report),Live Nation Entertainment, Inc. (NYSE:(LYV - Free Report) –Free Report) and Vertex Pharmaceuticals Incorporated (NASDAQ:(VRTX - Free Report) – Free Report).

Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free.

Here are highlights from Friday’s Analyst Blog:

5 Toxic Stocks to Cast Aside or Play Short

The proper identification of rightly priced stocks and overpriced stocks makes investing an easy task. However, in a complicated marketplace, the correctly priced stocks and their steeply priced counterparts are intertwined in such a way that making a distinction is tough. Nevertheless, figuring out the bloated toxic stocks on a regular basis and getting rid of them at the right time is one of the secrets to a winning investment strategy.


Generally, toxic companies are characterized by huge debt burdens and are susceptible to external shocks. Unjustifiably high price of the toxic stocks is short-lived as their current price is higher than their intrinsic value and these are bound to result into loss for investors over time.

Overpricing of the toxic stocks can be attributed to either an irrational exuberance associated with them or some serious fundamental lacunae. If you own such overblown stocks for a long period of time, you are bound to see considerable erosion of wealth.

However, if you can accurately identify such toxic stocks, you may gain by resorting to an investing strategy called short selling. This strategy allows you to sell a stock first and then buy it when the price falls.

While short selling excels in bear markets, it typically loses money in bull markets.

So, just like spotting stocks with growth potential, figuring out toxic stocks and abandoning them at the right time is the key to shield your portfolio from big losses or make profits by short selling them.

Screening Criteria

Here is a winning strategy that will help you identify the overhyped toxic stocks:

Most recent Debt/Equity Ratio greater than the median industry average: High debt/equity ratio implies high leverage. High leverage indicates a huge level of repayment that the company has to make in connection with the debt amount.

P/E using 12-month forward EPS estimate greater than 50: A very high forward P/E implies that a stock is highly overvalued.

% Change in F (1) and F (2) Estimate (12 Weeks) less than -2: Negative EPS estimate revision for this and the next fiscal year during the past 12 weeks points to analysts’ pessimism.

Zacks Rank more than or equal to #3 (Hold): We have not considered Buy-rated stocks that generally outperform the market.

Here are five of the 10 toxic stocks that showed up on the screen:

Houston, TX-based Cabot Oil & Gas Corporation (NYSE:(COG - Free Report) – Free Report) is an oil and gas company engaged in the exploration, development, acquisition and exploitation of oil and gas properties in the U.S. Over the past one-month period, its quarterly estimate has declined 40% to 3 cents. The stock currently has a Zacks Rank #3.

Boulder, CO-based Zayo Group Holdings, Inc. (NYSE:(ZAYO - Free Report) – Free Report) is a provider of bandwidth infrastructure solutions to the communications industry in the U.S., Canada, and Europe. Over the last 30 days, quarterly estimates remained stable at 5 cents a share. The company has a Zacks Rank #3. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here .

Etsy, Inc. (NASDAQ:(ETSY - Free Report) – Free Report) is a Brooklyn, NY-based Internet services company, which operates a marketplace to make, sell, and buy goods online and offline worldwide. Over the last 30 days, quarterly estimates remained stable at 1 cent a share. The company has a Zacks Rank #3.

Live Nation Entertainment, Inc. (NYSE:(LYV - Free Report) – Free Report) is a Beverly Hills, CA-based live entertainment company. Over the past one-month period, the quarterly estimate has declined 2% to 48 cents. The stock currently has a Zacks Rank #3.

Boston, MA-based Vertex Pharmaceuticals Incorporated (NASDAQ:(VRTX - Free Report) – Free Report) is a bio-technology company. Over the past one-month period, the current quarter estimate has moved down from 9 cents a share to a no loss, no gain situation. The stock currently has a Zacks Rank #4 (Sell).

Get the rest of the stocks on the list and start putting this and other ideas to the test. It can all be done with the Research Wizard stock picking and backtesting software.

The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.

Click here to sign up for a free trial to the Research Wizard today .

Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.

Disclosure: Performance information for Zacks’ portfolios and strategies are available at: https://www.zacks.com/performance.

Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1 Stock of the Day pick for free.

About Zacks Equity Research

Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.

Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.

Strong Stocks that Should Be in the News

Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has nearly tripled the market from 1988 through 2015. Its average gain has been a stellar +26% per year. See these high-potential stocks free >>.

Get the full Report on COG - FREE

Get the full Report on ZAYO - FREE

Get the full Report on ETSY - FREE

Get the full Report on LYV - FREE

Get the full Report on VRTX - FREE

Follow us on Twitter: https://twitter.com/zacksresearch

Join us on Facebook: https://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Media Contact
Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com

https://www.zacks.com/

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss.

This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.